New Zealand King Salmon reported an FY25 net loss driven by a shortened reporting period and biological challenges, while advancing its Blue Endeavour pilot project despite delays. The company projects a cautious recovery in FY26 with EBITDA guidance between NZD 9 million and 15 million.
New Zealand King Salmon reported a $20.8 million net loss for the half year ending July 2025, driven by biological setbacks and reduced harvests. Despite this, the company maintains a strong balance sheet and is advancing its Blue Endeavour pilot farm and growth initiatives.
New Zealand King Salmon Investments Limited reported a significant interim loss driven by biological asset valuation pressures and operational costs, while announcing a strategic $8.14 million property purchase.